Cryptosporidium parvum infection in gene-targeted B cell-deficient mice

Journal of Parasitology

Volumn 89, Issue 2, 2003, Pages 391-393

  Chen, Wangxue ^a   Harp, James A ^b   Harmsen, Allen G ^c  

^a NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^b NATIONAL ANIMAL DISEASE CENTER   (United States)

^c MONTANA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PARASITE RESISTANCE; PARASITOLOGY;

AGE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; GENE TARGETING; HOST RESISTANCE; KINETICS; LYMPHOCYTE DEPLETION; MOUSE; NEWBORN; NONHUMAN; SPLEEN CELL;

ANIMALS; ANIMALS, NEWBORN; B-LYMPHOCYTES; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; DISEASE MODELS, ANIMAL; FEMALE; IMMUNOCOMPROMISED HOST; MALE; MICE; MICE, INBRED C57BL;

ANIMALIA; CRYPTOSPORIDIUM PARVUM; PROTOZOA;

EID: 0037396543     PISSN: 00223395     EISSN: None     Source Type: Journal    
DOI: 10.1645/0022-3395(2003)089[0391:CPIIGB]2.0.CO;2     Document Type: Article

References (26)

1. AGUIRRE, S. A., L. E. PERRYMAN, W. C. DAVIS, AND T. C. McGUIRE. 1998. IL-4 protects adult C57BL/6 mice from prolonged Cryptosporidium parvum infection: Analysis of CD4+alpha beta+IFN-gamma+ and CD4+alpha beta+IL-4+ lymphocytes in gut-associated lymphoid tissue during resolution of infection. Journal of Immunology 161: 1891-1900.
2. BOWEN, D. L., H. C. LANE, AND A. S. FAUCI. 1985. Immunopathogenesis of the acquired immunodeficiency syndrome. Annals of Internal Medicine 103: 704-709.
3. CHEN, W., J. A. HARP, AND A. G. HARMSEN. 1993. Requirements for CD4+ cells and gamma interferon in resolution of established Cryptosporidium parvum infection in mice. Infection and Immunity 61: 3928-3932.
4. COSYNS, M., S. TSIRKIN, M. JONES, R. FLAVELL, H. KIKUTANI, AND A. R. HAYWARD. 1998. Requirement of CD40-CD40 ligand interaction for elimination of Cryptosporidium parvum from mice. Infection and Immunity 66: 603-607.
5. COZON, G., F. BIRON, M. JEANNIN, D. CANNELLA, AND J. P. REVILLARD. 1994. Secretory IgA antibodies to Cryptosporidium parvum in AIDS patients with chronic cryptosporidiosis. Journal of Infectious Diseases 169: 696-699.
6. DE GRAAF, D. C., F. SPANO, F. PETRY, S. SAGODIRA, AND A. BONNIN. 1999. Speculation on whether a vaccine against cryptosporidiosis is a reality or fantasy. International Journal of Parasitology 29: 1289-1306.
7. FLANIGAN, T., C. WHALEN, J. TURNER, R. SOAVE, J. TOERNER, D. HAVLIR, AND D. KOTLER. 1992. Cryptosporidium infection and CD4 counts. Annals of Internal Medicine 116: 840-842.
8. GRIFFITHS, J. K., C. THEODOS, M. PARIS, AND S. TZIPORI. 1998. The gamma interferon gene knockout mouse: A highly sensitive model for evaluation of therapeutic agents against Cryptosporidium parvum. Journal of Clinical Microbiology 36: 2503-2508.
9. HARP, J. A., W. CHEN, AND A. G. HARMSEN. 1992. Resistance of severe combined immunodeficient mice to infection with Cryptosporidium parvum: The importance of intestinal microflora. Infection and Immunity 60: 3509-3512.
10. KITAMURA, D., J. ROES, R. KUHN, AND K. RAJEWSKY. 1991. A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin μ chain gene. Nature 350: 423-426.
11. LANGHORNE, J., C. CROSS, E. SEIXAS, C. LI, AND T. VON DER WEID. 1998. A role for B cells in the development of T cell helper function in a malaria infection in mice. Proceedings of the National Academy of Sciences of the United States of America 95: 1730-1734.
12. LAUGHON, B. E., H. S. ALLAUDEEN, J. M. BECKER, W. L. CURRENT, J. FEINBERG, J. K. FRENKEL, R. HAFNER, W. T. HUGHES, C. A. LAUGHLIN, J. D. MEYERS, L. K. SCHRAGER, AND L. S. YOUNG. 1991. Summary of the workshop on future directions in discovery and development of therapeutic agents for opportunistic infections associated with AIDS. Journal of Infectious Diseases 164: 244-251.
13. LEITCH, G. J., AND Q. HE. 1994. Arginine-derived nitric oxide reduces fecal oocyst shedding in nude mice infected with Cryptosporidium parvum. Infection and Immunity 62: 5173-5176.
14. -, AND - 1999. Reactive nitrogen and oxygen species ameliorate experimental cryptosporidiosis in the neonatal BALB/c mouse model. Infection and Immunity 67: 5885-5891.
15. McDONALD, V., AND G. J. BANCROFT. 1998. Immunological control of Cryptosporidium infection. Chemical Immunology 70: 103-123.
16. MEAD, J. R., M. J. ARROWOOD, R. W. SIDWELL, AND M. C. HEALEY. 1991. Chronic Cryptosporidium parvum infections in congenitally immunodeficient SCID and nude mice. Journal of Infectious Diseases 163: 1297-1304.
17. MOMBAERTS, P., J. IACOMINI, R. S. JOHNSON, K. HERRUP, S. TONEGAWA, AND V. E. PAPAIOANNOU. 1992. RAG-1-deficient mice have no mature B and T lymphocytes. Cell 68: 869-877.
18. PERRYMAN, L. E., P. H. MASON, AND C. E. CHRISP. 1994. Effect of spleen cell populations on resolution of Cryptosporidium parvum infection in SCID mice. Infection and Immunity 62: 1474-1477.
19. SOAVE, R., AND W. D. JOHNSON JR. 1988. Cryptosporidium and Isospora belli infections. Journal of Infectious Diseases 157: 225-229.
20. TAGHI-KILANI, R., L. SEKLA, AND K. T. HAYGLASS. 1990. The role of humoral immunity in Cryptosporidium spp. infection. Studies with B cell-depleted mice. Journal of Immunology 145: 1571-1576.
21. UNGAR, B. L., T. C. KAO, J. A. BURRIS, AND F. D. FINKELMAN. 1991. Cryptosporidium infection in an adult mouse model. Independent roles for IFN-gamma and CD4+ T lymphocytes in protective immunity. Journal of Immunology 147: 1014-1022.
22. URBAN, J. F., JR., R. FAYER, S. J. CHEN, W. C. GAUSE, M. K. GATELY, AND F. D. FINKELMAN. 1996. IL-12 protects immunocompetent and immunodeficient neonatal mice against infection with Cryptosporidium parvum. Journal of Immunology 156: 263-268.
23. WATERS, W. R., AND J. A. HARP. 1996. Cryptosporidium parvum infection in T-cell receptor (TCR)-alpha- and TCR-delta-deficient mice. Infection and Immunity 64: 1854-1857.
24. WEINER, C., Q. PAN, M. HURTIG, T. BORÉN, E. BOSTWICK, AND L. HAMMARSTRÖM. 1999. Passive immunity against human pathogens using bovine antibodies. Clinical and Experimental Immunology 116: 193-205.
25. WHITE, A. C., P. ROBINSON, P. C. OKHUYSEN, D. E. LEWIS, I. SHAHAB, S. LAHOTI, H. L. DUPONT, AND C. L. CHAPPELL. 2000. Interferon-gamma expression in jejunal biopsies in experimental human cryptosporidiosis correlates with prior sensitization and control of oocyst excretion. Journal of Infectious Diseases 181: 701-709.
26. Zu, S., G. GANG, R. FAYER, AND R. GUERRANT. 1992. Cryptosporidiosis, pathogenesis and immunology. Parasitology Today 8: 24-27.